share_log
Breakings ·  Jun 17 09:45

The Hong Kong stock market's CNI Biomedicine Index continues to be active, with Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co. Ltd. rising over 16%, Joinn Laboratories increasing over 6%, and Ascentage Pharma, WUXI XDC, and I-Mab rising over 3%.

The translation is provided by third-party software.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment